STROMUSC Drostanolone Propionate 100mg For Bodybuilding CAS:58-19-5
Drostanolone Propionate, commonly known by its trade name Masteron, is a synthetic anabolic-androgenic steroid (AAS) derived from dihydrotestosterone (DHT). Initially developed in the 1960s for treating breast cancer, its application shifted to bodybuilding due to its unique ability to enhance muscle definition and reduce estrogenic side effects.
Introduction
Drostanolone Propionate, commonly known by its trade name Masteron, is a synthetic anabolic-androgenic steroid (AAS) derived from dihydrotestosterone (DHT). Initially developed in the 1960s for treating breast cancer, its application shifted to bodybuilding due to its unique ability to enhance muscle definition and reduce estrogenic side effects. Unlike many steroids, Drostanolone is prized during cutting phases for its capacity to preserve lean mass while promoting a hardened, vascular physique. This article delves into its chemical profile, mechanisms, applications, and protocols, offering fresh insights beyond conventional summaries.
Chemical Profile and Features
Drostanolone Propionate belongs to the DHT family, modified by the addition of a methyl group at the carbon-2 position, which resists enzymatic breakdown (e.g., by 5α-reductase). The propionate ester attached to the 17β-hydroxyl group dictates its pharmacokinetics, enabling a slow release into the bloodstream. Key features include:
●Androgenic Ratio: With a moderate androgenic rating (25-40) and anabolic rating (62-130), it favors muscle retention over rapid hypertrophy.
●Non-aromatizing: Lacks estrogenic activity, making it ideal for users prone to gynecomastia or water retention.
●Lipid Solubility: Its structure allows efficient binding to androgen receptors in adipose tissue, aiding fat metabolism.
Unlike its cousin Drostanolone Enanthate, the propionate ester necessitates frequent injections (every 2-3 days) due to a shorter half-life. This ester difference impacts both user convenience and cycle design.
Mechanism of Action
Drostanolone operates through dual pathways:
●Androgen Receptor Activation: Binds strongly to muscle and fat cell receptors, enhancing protein synthesis and lipolysis.
●Antagonizing Estrogen: Competes with estrogen for receptor sites, indirectly reducing soft tissue fluid retention.
A lesser-known mechanism involves its inhibition of corticosteroid-binding globulin (CBG), potentiating the effects of endogenous cortisol in breaking down subcutaneous fat. This synergy explains its efficacy in pre-contest phases when athletes aim for extreme leanness.
Applications in Bodybuilding
Primarily used during cutting cycles, Drostanolone's applications extend beyond mere fat loss:
●Muscle Preservation: Prevents catabolism in calorie-deficit states by maintaining nitrogen balance.
●Aesthetic Enhancement: Enhances vascularity and muscle "graininess" by reducing interstitial water.
●Synergistic Stacking: Often paired with non-aromatizing agents like Trenbolone or Stanozolol to amplify hardness.
Advanced users occasionally incorporate low doses in bulking phases to mitigate estrogenic bloat from aromatizing steroids like Testosterone or Dianabol, though this is less common.
Benefits Beyond Conventional Steroids
●Estrogen Mitigation: Unlike aromatase inhibitors (AIs), which block estrogen synthesis, Drostanolone's receptor-level competition offers a unique approach to managing estrogenic effects without crashing estrogen levels entirely.
●Psychological Edge: Users report heightened aggression and focus, likely due to DHT's neurostimulatory effects.
●Minimal Hepatotoxicity: As a non-17α-alkylated compound, it poses lower liver stress compared to oral AAS.
Anecdotal evidence suggests it may improve collagen synthesis, supporting joint health-a rare benefit in cutting agents known for drying out connective tissues.
Dosage and Administration
●Men: 300–600 mg weekly, divided into 3–4 injections (e.g., 100 mg every other day). Higher doses (>600 mg) yield diminishing returns and amplify side effects.
●Women: Rarely used due to androgenic risks (virilization), though some female competitors microdose at 50–100 mg weekly.
Drostanolone is typically injected intramuscularly, though its propionate ester allows for shallow IM or subcutaneous administration with proper technique. Oral forms are nonexistent due to rapid hepatic inactivation.
Cycle Design and Timing
Cycles last 8–12 weeks, aligning with the propionate ester's short half-life (2–3 days). Example protocols:
●Solo Cutting Cycle: 400 mg/week Drostanolone + calorie deficit + high-intensity training.
●Competition Stack: 500 mg/week Drostanolone + 300 mg/week Trenbolone Acetate + 50 mg/day Stanozolol.
Front-loading is unnecessary due to the ester's rapid release. Post-injection peaks occur within 24–48 hours, requiring consistent dosing to maintain stable blood levels.
Half-Life and Metabolic Clearance
The propionate ester extends Drostanolone's active half-life to ~2–3 days, necessitating injections every other day. Metabolized via hepatic glucuronidation, its metabolites are excreted renally. Unlike long esters, its rapid clearance allows quicker post-cycle recovery but demands disciplined administration.
Post-Cycle Therapy (PCT)
Despite mild androgenic suppression, Drostanolone necessitates PCT to restore hypothalamic-pituitary-testicular axis (HPTA) function. A 4–6 week protocol starting 3 days post-last injection includes:
●Clomiphene Citrate: 50 mg/day for 30 days.
●Tamoxifen: 20 mg/day for 45 days.
●hCG (Optional): 500 IU every other day for 2 weeks pre-PCT to jumpstart Leydig cells.
Blood work (testosterone, LH, FSH, lipids) is critical to tailor recovery, as Drostanolone can suppress HDL cholesterol by up to 30%.
Risk Mitigation and Controversies
●Cardiovascular Stress: Drostanolone reduces HDL ("good" cholesterol), necessitating omega-3 supplementation and cardio exercise.
●Androgenic Side Effects: Acne, hair loss (in predisposed individuals), and prostate irritation.
●Legality: Classified as a Schedule III drug in the U.S., with non-medical use prohibited globally.
Debates persist about its efficacy as a standalone agent, with critics arguing its benefits are overstated without synergistic compounds.
Novel Insights and Future Directions
Emerging research explores Drostanolone's potential in treating cachexia and osteoporosis, leveraging its anti-catabolic properties. In bodybuilding, trends show a shift toward microdosing in "cruise" phases to maintain leanness year-round. Additionally, genetic polymorphisms in the AR gene may explain variability in user responses, paving the way for personalized steroid protocols.
Clinical Data
|
Brand |
STROMUSC |
|
Trade names |
Drolban, Masteril, Masteron, Dromostanolone propionate; NSC-12198; Drostanolone 17β-propionate; |
|
CAS |
58-19-5 |
|
Molar mass |
360.538 |
|
Formula |
C23H36O3 |
|
Purity |
Above 98% |
|
Apprarance |
100mg/ml, 10ml/bottle |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-19128233885
Conclusion
Drostanolone Propionate remains a cornerstone of contest preparation, offering a blend of aesthetic enhancement and metabolic efficiency unmatched by many AAS. Its niche lies in strategic use rather than mass gain, demanding a nuanced understanding of its pharmacokinetics and user-specific adaptation. As the bodybuilding landscape evolves, so too will its applications, underscoring the need for ongoing education and harm reduction practices.
Hot Tags: stromusc drostanolone propionate 100mg for bodybuilding cas:58-19-5, China stromusc drostanolone propionate 100mg for bodybuilding cas:58-19-5 manufacturers, suppliers, factory
